Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6226)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kontana A, Tziomalos K. Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. World J Gastroenterol 2019; 25(28): 3664-3668 [PMID: 31391764 DOI: 10.3748/wjg.v25.i28.3664] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i28/3664.htm |
| Number | Citing Articles |
| 1 |
Kavita Garg, Trenton Reinicke, Satish K. Garg. NAFLD and NASH and Diabetes. Diabetes Technology & Therapeutics 2021; 23(S2): S-198 doi: 10.1089/dia.2021.2515
|
| 2 |
Mario Simental-Mendía, Adriana Sánchez-García, Mariana Rodríguez-Ramírez, Luis E. Simental-Mendía. Effect of sodium-glucose co-transporter 2 inhibitors on hepatic parameters: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 2021; 163: 105319 doi: 10.1016/j.phrs.2020.105319
|
| 3 |
Virginia Bellido, Julia Martínez, Fernando Calvo, Aida Villarroel, Edurne Lecumberri, Juan Moreno, Carlos Morillas, Silvia Rodrigo, Aitziber Izarra, Albert Lecube. Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications. Diabetes Therapy 2022; 13(5): 873 doi: 10.1007/s13300-022-01237-9
|
| 4 |
Tiantian Song, Shuchun Chen, Hang Zhao, Fei Wang, Huan Song, Dongliang Tian, Qiwen Yang, Licui Qi. Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver disease. Hepatology Research 2021; 51(6): 641 doi: 10.1111/hepr.13645
|
| 5 |
Meng Yang, Chang-An Geng, Xinguang Liu, Min Guan. Lipid Disorders in NAFLD and Chronic Kidney Disease. Biomedicines 2021; 9(10): 1405 doi: 10.3390/biomedicines9101405
|
| 6 |
Junwei Shao, Tiantian Ge, Yingliang Wei, Yuhan Zhou, Mengyuan Shi, Huiyuan Liu, Zhi Chen, Yang Xia. Co-interventions withClostridium butyricumand soluble dietary fiber targeting the gut microbiota improve MAFLDviathe Acly/Nrf2/NF-κB signaling pathway. Food & Function 2022; 13(10): 5807 doi: 10.1039/D1FO04224F
|